Transcat, Inc (NASDAQ:TRNS) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07 Submission of Matters to a Vote of Security Holders.
At the annual meeting of shareholders of Transcat, Inc. (the “Company”) held on September 12, 2018, the Company’s shareholders voted on the matters described below.
| Proposal 1. | The Company’s shareholders elected the following nominees as directors, each to serve for a three-year term expiring in 2021. |
| Director Nominee | Votes For | Authority Withheld | Broker Non-Votes |
| Alan H. Resnick | 5,054,429 | 27,569 | 1,288,611 |
| Lee D. Rudow | 5,007,827 | 74,172 | 1,288,611 |
| Carl E. Sassano | 3,748,146 | 1,333,852 | 1,288,611 |
| Proposal 2. | The Company’s shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers. |
| Votes For | Votes Against | Votes Abstained | Broker Non-Votes |
| 4,944,715 | 131,627 | 5,656 | 1,288,611 |
| Proposal 3. | The Company’s shareholders ratified the selection of Freed Maxick CPAs, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending March 30, 2019. |
| Votes For | Votes Against | Votes Abstained |
| 6,359,382 | 8,096 | 3,131 |
About Transcat, Inc (NASDAQ:TRNS)
Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak). Through its Distribution segment, the Company markets, sells and rents national brand instruments to customers around the globe. The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses.
